Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 12.14
(3.67%)
INR 12.14
(3.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 79.64 Million INR | -20.02% |
| 2022 | 99.59 Million INR | -20.65% |
| 2021 | 125.51 Million INR | 17.17% |
| 2020 | 107.12 Million INR | -30.74% |
| 2019 | 154.67 Million INR | 38.53% |
| 2018 | 111.65 Million INR | 0.91% |
| 2017 | 110.64 Million INR | -2.38% |
| 2016 | 113.34 Million INR | 43.88% |
| 2015 | 78.77 Million INR | 95.13% |
| 2014 | 40.37 Million INR | 0.0% |
| 2013 | - INR | 0.0% |
| 2012 | - INR | 0.0% |
| 2011 | - INR | 0.0% |
| 2010 | - INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 79.64 Million INR | -20.02% |
| 2023 Q4 | 79.64 Million INR | 0.0% |
| 2023 Q2 | 92.56 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 99.59 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 99.59 Million INR | -20.65% |
| 2022 Q2 | 133.95 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 125.51 Million INR | 0.0% |
| 2021 Q2 | 160.13 Million INR | 0.0% |
| 2021 FY | 125.51 Million INR | 17.17% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | 115.1 Million INR | -3.04% |
| 2020 Q4 | 107.12 Million INR | -6.94% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 107.12 Million INR | -30.74% |
| 2020 Q2 | 118.7 Million INR | 0.0% |
| 2019 Q4 | 154.67 Million INR | 0.0% |
| 2019 FY | 154.67 Million INR | 38.53% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 108.49 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 111.65 Million INR | 0.91% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 111.65 Million INR | 0.0% |
| 2018 Q2 | 121.24 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 110.64 Million INR | -2.38% |
| 2017 Q4 | 110.64 Million INR | 0.0% |
| 2017 Q2 | 123.63 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 113.34 Million INR | 43.88% |
| 2016 Q4 | 114.14 Million INR | 62.56% |
| 2016 Q3 | 70.21 Million INR | -3.8% |
| 2016 Q2 | 72.99 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 78.77 Million INR | 95.13% |
| 2015 Q2 | 78.29 Million INR | 0.0% |
| 2015 Q4 | 78.77 Million INR | -7.79% |
| 2015 Q3 | 85.42 Million INR | 9.12% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | 40.37 Million INR | 0.0% |
| 2014 Q4 | 40.37 Million INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2013 Q1 | - INR | 0.0% |
| 2013 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | - INR | 0.0% |
| 2011 FY | - INR | 0.0% |
| 2011 Q4 | - INR | 0.0% |
| 2010 FY | - INR | 0.0% |
| 2010 Q4 | - INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | -211.57% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 81.777% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -1279.664% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -309.186% |
| Sunil Healthcare Limited | 661.51 Million INR | 87.96% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.211% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 88.658% |
| Patidar Buildcon Limited | 25.32 Million INR | -214.528% |
| Roopa Industries Limited | 258.54 Million INR | 69.194% |
| Smruthi Organics Limited | 117.03 Million INR | 31.945% |
| Trident Lifeline Limited | 184.1 Million INR | 56.737% |
| PANJON LTD. | 14.36 Million INR | -454.304% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 6.657% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | -105.995% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -438.162% |
| Anuh Pharma Limited | 26.92 Million INR | -195.781% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -7180.439% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -12482.622% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 92.451% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | -152.538% |
| Norris Medicines Limited | 215.23 Million INR | 62.995% |
| Zenlabs Ethica Limited | 148.59 Million INR | 46.4% |
| Vikram Thermo (India) Limited | 70.43 Million INR | -13.077% |
| ANG Lifesciences India Limited | 728.36 Million INR | 89.065% |
| Parmax Pharma Limited | 53.72 Million INR | -48.257% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | -320.284% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 92.403% |
| Makers Laboratories Limited | 194.92 Million INR | 59.138% |
| Lactose (India) Limited | 392.52 Million INR | 79.709% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 86.084% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -721.876% |
| Bacil Pharma Limited | 984 Thousand INR | -7994.309% |
| PRAVEG LIMITED | 596.11 Million INR | 86.639% |
| Denis Chem Lab Limited | 10.46 Million INR | -661.453% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 91.883% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | -1297.824% |
| Godavari Drugs Limited | 556.24 Million INR | 85.681% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | -26.243% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 78.148% |
| Vivanza Biosciences Limited | 51.69 Million INR | -54.073% |
| Phaarmasia Limited | 1.44 Million INR | -5427.273% |
| Sastasundar Ventures Limited | 38.82 Million INR | -105.13% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -187.704% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 82.727% |
| Mercury Laboratories Limited | 55.53 Million INR | -43.417% |
| Gennex Laboratories Limited | 57.2 Million INR | -39.233% |
| BDH Industries Limited | 86.9 Million INR | 8.353% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 52.002% |
| Bharat Parenterals Limited | 1.57 Billion INR | 94.946% |
| Beryl Drugs Limited | 50.93 Million INR | -56.36% |
| Evoq Remedies Limited | 42.38 Million INR | -87.929% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 37.648% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 90.123% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -227465.714% |
| Kerala Ayurveda Limited | 675.77 Million INR | 88.214% |
| Cian Healthcare Limited | 556.91 Million INR | 85.698% |
| Trinity League India Limited | 242 Thousand INR | -32812.397% |
| Syschem (India) Limited | 4.5 Million INR | -1669.956% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 94.298% |
| Natural Capsules Limited | 1.09 Billion INR | 92.693% |
| Auro Laboratories Limited | 262.43 Million INR | 69.651% |